1. Home
  2. SLQT vs TKNO Comparison

SLQT vs TKNO Comparison

Compare SLQT & TKNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SelectQuote Inc.

SLQT

SelectQuote Inc.

HOLD

Current Price

$1.35

Market Cap

281.6M

Sector

Finance

ML Signal

HOLD

Logo Alpha Teknova Inc.

TKNO

Alpha Teknova Inc.

HOLD

Current Price

$4.56

Market Cap

236.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SLQT
TKNO
Founded
1999
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Specialty Insurers
Medicinal Chemicals and Botanical Products
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
281.6M
236.6M
IPO Year
2020
2021

Fundamental Metrics

Financial Performance
Metric
SLQT
TKNO
Price
$1.35
$4.56
Analyst Decision
Hold
Analyst Count
2
0
Target Price
$3.88
N/A
AVG Volume (30 Days)
878.2K
114.8K
Earning Date
02-09-2026
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,563,142,000.00
$39,801,000.00
Revenue This Year
$13.00
$8.79
Revenue Next Year
$7.65
$10.52
P/E Ratio
$10.82
N/A
Revenue Growth
13.16
9.50
52 Week Low
$1.33
$3.94
52 Week High
$6.86
$10.37

Technical Indicators

Market Signals
Indicator
SLQT
TKNO
Relative Strength Index (RSI) 38.17 46.63
Support Level $1.35 $4.53
Resistance Level $1.46 $4.86
Average True Range (ATR) 0.08 0.26
MACD 0.01 0.01
Stochastic Oscillator 4.35 37.74

Price Performance

Historical Comparison
SLQT
TKNO

About SLQT SelectQuote Inc.

SelectQuote Inc is a Direct-to-consumer (DTC) distribution platform which facilitates consumers to shop for health, life and auto & home insurance policies online. The company generates its revenues by selling insurance products on behalf of the insurance carrier partners in the form of a commission. It has four reportable segments namely Senior, Healthcare Services, Life, and Auto & Home. It functions through three lines namely, SelectQuote Senior, SelectQuote Life, and SelectQuote Auto & Home.

About TKNO Alpha Teknova Inc.

Alpha Teknova Inc provides critical reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Its offer three product types: pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It derives key revenue from United States.

Share on Social Networks: